Follow-up of hepatitis C virus infection in chimpanzees: determination of viraemia and specific humoral immune response
|
|
- Jerome Sutton
- 6 years ago
- Views:
Transcription
1 Journal of General Virology (1992), 73, Printed in Great Britain 1015 Follow-up of hepatitis C virus infection in chimpanzees: determination of viraemia and specific humoral immune response J. Hilfenhaus, 1. U. Krupka, 1 T. Nowak, 1 L. B. Cummins, 2 K. Fuchs 3 and M. Roggendorf 4 1Behringwerke AG, P.O. Box 11 40, D-35 Marburg, Germany, 2White Sands Research Center, 1300 La Velle Road, Alamogordo, New Mexico 88310, U.S.A., 3Max yon Pettenkofer-lnstitut, Pettenkoferstrasse 9a, D-8000 Mi~nchen 2 and 41nstitut fur Virologie, University of Essen, Hufelandstrasse 55, D-4300 Essen, Germany Chimpanzees were inoculated intravenously with the H strain of hepatitis C virus (HCV), and analysed for viraemia using the polymerase chain reaction and for a humoral immune response using first and second generation anti-hcv ELSAs and an immunoblot assay (4-RBA). n all seven chimpanzees studied, viraemia occurred several weeks before a significant increase in serum alanine transferase (ALT) activity, whereas the first circulating anti-hcv antibodies became detectable at the time of significant increase in ALT levels, provided the second generation ELSA or 4-RBA was used. On the basis of the duration of viraemia the chimpanzees studied could be assigned to two different groups: those in which viraemia dis- appeared in conjunction with or shortly after seroconversion, and those remaining viraemic for many weeks after the appearance of antibodies. The clearance of HCV from the circulation did not correlate with the antibody pattern determined using 4-RBA, i.e. the HCV-specific assays currently available do not enable us to predict whether an infected chimpanzee will develop persistent viraemia. Only two of the seven chimpanzees analysed developed anti-core protein () antibodies, which appeared at the same time as the first ALT peak, whereas all animals developed antibodies to the non-structural protein,, and these antibodies persisted. Only after the hepatitis C virus (HCV) genome had been cloned by Choo et al. (1989) was it possible to develop specific assays, such as ELSA, recombinant immunoblot assay (RBA) and the polymerase chain reaction (), to diagnose HCV infection. These assays can now be used to study the development of viraemia and the specific immune response in HCV-infected chimpanzees, the only experimental animals sensitive to HCV. Shimizu et al. (1990) published a study on the early stages of HCV infection in chimpanzees, focusing on the determination of viraemia by. Their study of the humoral immune response was limited to the first generation assay, detecting antibodies to c- only, a recombinant polypeptide that represents part of a nonstructural HCV protein. We have extended these studies on HCV viraemia and the specific immune response in chimpanzees using the assays developed most recently. The seven animals investigated were positive (HCV-infected) controls from studies in which the inactivation of HCV by various methods included in the procedures for manufacturing human plasma proteins for therapeutic use had been studied (Mauler et al, 1987). The HCV isolate used for spiking the source plasma preparations in these studies was the human H pool plasma, now designated H strain (Ogata etal., 1991). Chimpanzees inoculated with HCVspiked human plasma or plasma derivatives were regarded as being HCV-infected when the serum alanine transferase (ALT) activity increased significantly, and infections with hepatitis A virus (HAV), hepatitis B virus (HBV) and the human herpesviruses, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), could be excluded. We demonstrate that the chimpanzees either cleared the infection or developed persistent viraemia despite the presence of serum antibodies which became detectable at approximately the same time as the first peak of the increase in ALT levels. The inoculum for all chimpanzees infected was diluted with human plasma. A sample of the HCV H strain isolate containing chimpanzee ~ infectious doses (CDs0)ml of HCV (Feinstone et al., 1981) was kindly provided by Dr R. H. Purcell (National nstitute of Allergy and nfectious Diseases, NH, Bethesda, Md., U.S.A.) (Ogata et al., 1991). According to the aim of our former HCV safety studies, various amounts of this virus
2 1016 Short communication sample were used to spike human plasma. Aliquots of various spiked HCV source plasmas were then inoculated intravenously into the chimpanzees, giving between CDs0 and CDso per chimpanzee. The animals used had experienced neither an HBV or HCV infection before inoculation with the HCV-spiked plasma samples. Furthermore, they had normal ALT activities, as determined weekly over a period of 3 months before HCV inoculation. nfections of these chimpanzees with HAV, CMV and EBV were excluded by assaying for specific antibodies before HCV inoculation and at the end of the study (22 to 40 weeks postinfection). Serum samples were taken weekly and assayed for ALT, HBsAg, and anti-hbc and anti-hbs antibodies using commercial assays. Liver biopsies were taken monthly, starting immediately before HCV inoculation, and routinely studied microscopically. Furthermore, biopsies taken before inoculation and after a significant increase in the level of ALT were carefully investigated by electron microscopy (EM). Before specific HCV assays were available, chimpanzees which developed a significant increase in ALT (at least twofold greater than the individual baseline during the 3 month period before HCV inoculation) and cytoplasmic tubular structures in hepatocytes detectable by EM (as described by Shimizu et al., 1990), but which did not show any parameters of HAV, HBV, CMV or EBV infection, had been designated as being HCV-infected. Analysis of viraemia in the HCV-inoculated chimpanzees was done using nested to amplify a nucleotide sequence at the 5' end of the HCV genome (Garson et al., 1990a; Fuchs et al., 1991). Briefly, reverse transcription was done using cloned Moloney murine leukaemia virus reverse transcriptase. Sequences between nucleotides (nt) were used as primers, namely nt 1 and 20 and nt 305 and 324 of the HCV J1 isolate as outer primers and those from nt 21 to 31 and nt 271 to 286 as nested primers. Nucleotides are numbered according to Okamoto et al. (1990). Single bands of 324 bp after the first round of and of 265 bp after the second round were visible in the agarose gel after ethidium bromide staining. To avoid false negatives, the results of on serum samples thawed not more than twice were used. Circulating antibodies to the HCV peptide c- were detected by using the commercially available first generation ELSA (Ortho Diagnostic Systems) as recommended by the manufacturer. However, the conjugate included in the commercial assay was replaced with a rabbit anti-human gg peroxidase conjugate, used at a fourfold greater concentration to achieve satisfactory cross-reactivity with chimpanzee gg. n addition, a second generation ELSA was used; this employed the recombinant polypeptides ( and c-) which contain amino~acid sequences from non-structural proteins and the core region of HCV (Ortho Diagnostic Systems). Sera producing an absorbance (A4) > 0.5 were regarded as being anti-hcv-positive. To identify the HCV proteins to which antibodies developed, a RBA involving individual peptides c, c-, (nonstructural proteins) and (core protein) was used as described by the manufacturer (4-RBA assay; Chiron). The development of viraemia determined using, and the immune response analysed with the various HCV antibody assays are shown for each of the seven HCV-infected chimpanzees studied (Fig. 1). Three of the seven animals (Fig. 1 a to c) cleared viraemia with the appearance of the first detectable antibodies. n three cases (Fig. 1 d to f) this clearance was delayed by a few weeks, and one animal (Fig. l g) remained viraemic throughout the whole 40 week observation period despite having serum antibodies. An example of each of these different groups will be discussed in more detail. The chimpanzee analysed in Fig. 1 (a), which had been inoculated with CDso HCV, was -negative 14 days after inoculation, but positive on day 28. ALT levels increased significantly 10 weeks after inoculation and specific antibodies were found 12 weeks after inoculation. When specific antibodies became detectable with the second generation ELSA, the became negative, i.e. HCV and specific antibodies were not present in the circulation at the same time. According to the RBA this animal developed antibodies to c-, and 5-1-1, but not to. n Fig. 1 (d) the results obtained for a chimpanzee inoculated with CDso HCV show that although viraemia disappeared shortly after the peak in ALT activity, antibodies to HCV and viraemia occurred simultaneously in the serum for a period of 5 weeks. This animal developed antibodies not only to, c- and 5-1-1, but also to. The anti- antibodies were not detectable after 16 weeks post-inoculation. Finally, Fig. 1 (g) shows the results obtained for an animal infected with CDso HCV which developed a persistent HCV infection. nstead of an obvious ALT peak, fluctuating increased levels of ALT activity were present over a long period of time. This was accompanied by viraemia, which started 2 weeks after inoculation and lasted until the end of the 40 week observation period. Antibodies to and c- were first detectable in week 38, whereas those to appeared in week 22. No anti- antibodies were detected. Using and various antibody detection assays we studied the course of viraemia and the humoral immune response to HCV in seven HCV-infected chimpanzees. nflammation of the liver became detectable by the significant increase in ALT levels in the sera of these animals 8 to 16 weeks after infection, and viremia
3 Short communication t5-1-1t - (a) c-l~ i + ~ ~ + ~ : 1 (8) c-lo ~4 ~ N N N k PC~ , , ~ ) ',~ 0.E,-1 < 1 c- c-i l: ~_ t0 t3 42 0!3 z o E o.= e~,.d < (' ++i + + q4 t~ ttt t4t , 1 [ 0 (g) c-lo _ + t t- 4+,bt+ ~ ~ ~ ~ ~ E 2~ ~Z -~ (d) c-lo0 i ~ t+ H-t-~ ~ "1- -- Pr p Time after inoculation (weeks) 0 ~... ~ --'i:::~'<= ~ Time after inoculation (weeks) Fig. 1. Follow-up of ALT levels (O), and the humoral immune response assayed with the first (D) or second generation ELSA (x~ in seven HCV-infected chimpanzees (a to g). Viraemia was determined by specific amplification. HCV proteins were detected using 4- RBA. The chimpanzees in (a) to (g) were inoculated at week 0 with 5.5, 4.2, 3.8, 3.2, 4.6, 3.2 and 3.5 loglo CDso of HCV, respectively. occurred several weeks before the increase in ALT. Since serum samples taken bi-weekly starting on the day of HCV inoculation were tested, the 14 day sample was the earliest that could be positive by (three animals). n two of the seven chimpanzees studied we did not detect HCV RNA in the serum before day 28, and in two other animals no HCV RNA was detected before day 42. By contrast, Shimizu et al. (1990), who analysed viraemia in chimpanzees infected with CD5o HCV daily, found the serum samples to be -positive three days after inoculation. n our experiments the amount of infectious HCV
4 1018 Short communication inoculated varied from 3-2 to 5.5 loglo CDso per animal. n these experiments we did not find any correlation between the amount of HCV inoculated and the development of viraemia or the increase in levels of ALT. Prince et al. (1983) have reported that the increase in serum transaminase occurs earlier after infection with greater amounts of infectious HCV inoculated. However, this correlation varies considerably from animal to animal. Specific serum antibodies were detected using the second generation ELSA at the time of the increase in ALT. n contrast, the first generation ELSA yielded positive results considerably later. The failure of this ELSA to detect seroconversion soon after infection has been observed by others (Weiner et al., 1990; van der Poel et al., 1991). When the chimpanzee sera were analysed with the 4-RBA, we found positive reactions at the same time as or 2 weeks after the first positive results obtained using the second generation ELSA. However, the pattern of the antibody response differed from chimpanzee to chimpanzee. Anti- antibodies were usually the first to become detectable. Chiba et al. (1991) and Harada et al. (1991) found that anti-, directed against the core protein," appeared much earlier in human serum than anti-c- antibodies. Nasoff et al. (1991) have reported that antibodies to an immunodominant epitope of the capsid protein develop frequently and early after infection in humans as well as in chimpanzees. However, we detected anti- antibodies in only two of seven animals. Among the HCV-infected chimpanzees studied, we found that most of them cleared viraemia concurrently with or shortly after the appearance of the first specific antibodies, and that only one animal remained viraemic during the entire observation period of 40 weeks. The pattern of antibodies detected using the 4-RBA did not show any significant differences between the persistently infected animal and those which cleared the viraemia. The pathogenesis of HCV infection in humans and chimpanzees is not yet fully understood. The rate of chronic infection in our chimpanzee group seems to be lower than that in humans inoculated with HCVcontaminated blood factor V (Garson et al., 1990b). Farci et al. (1991) have reported that two of four chimpanzees became chronically infected. More data on HCV infections in chimpanzees have to be collected to allow a conclusion to be reached as to whether the rate of chronic infection differs in chimpanzees and humans. These data also provide some valuable information regarding the prevention of HCV transmission by exclusion of anti-hcv antibody-positive human blood or plasma donations. Esteban et al. (1990) have reported that about 90~ of human blood donors with anti-c- antibodies have infectious virus in their blood. The authors conclude that screening for anti-c- antibodies using the first generation ELSA should prevent about half of the cases of transfusion-associated hepatitis. From our data it is obvious that the risk of transmission of HCV could be even further reduced by the use of the second generation ELSA. Furthermore, seropositive donations selected with the assays currently available may or may not contain infectious HCV. However, there will also be anti-hcv antibody-negative samples donated early after infection which will contain infectious HCV. Therefore a sensitive assay detecting HCV or HCV antigens would be highly desirable. For Professor Dr Hans-Gerhard Schwick on the occasion of his th year at Behringwerke AG. The skilful work of the staff of the White Sands Research Center, Alamogordo, New Mexico, who maintained the chimpanzees and did the HCV studies in these animals is gratefully acknowledged. Moreover, we very much appreciate the excellent technical assistance of Mrs G. Ernst, who performed the serum assays. We are grateful to Mrs A. Kirch for typing and preparing the manuscript. Parts of this study were supported by the Fritz Bender Foundation, Munich, Germany. References CHBA, J., OHBA, H., MATSUURA, Y., WATANABE, Y., KATAYAMA, T., KKUCH, S., SATO,. & MYAMURA, T. (1991). Serodiagnosis of hepatitis C virus (HCV) with an HCV core protein molecularly expressed by a recombinant baculovirus. Proceedings of the National Academy of Sciences, U.S.A. 88, Cnoo, Q. L., Kuo, G., WENER, A. J., OVERBY, L. R., BRADLEY, D. W. & HOUGHTON, M. (1989). solation of a cdna clone derived from a blood-borne non-a, non-b viral hepatitis genome. Science 244, ESTEBAN, J. J., GONZALEZ, A., HERNANDEZ, J. M., VLADOMU, L., SANCHEZ, C., LOPEZ-TALAVERA, J. C., LUCEA, D., MARTN-VEGA, C., VDAL, X., ESTEBAN, R. & GUARDA, J. (1990). Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. New England Journal of Medicine 323, FARC, P., ALTER, H. J., WONG, D., MLLER, R. H., SHH, J. W. JETT, B. & PURCELL, R. H. (1991). A long-term study of hepatitis C virus replication in non-a, non-b hepatitis. New England Journal of Medicine 325, FENSTONE, S. i., ALTER, H. J., DENES, H. P., SHMZU, Y. K., POPPER, H., BLACKMORE, D., SLY, D., LONDON, W. T. & PURCELL, R. H. (1981). NonAnonB hepatitis in chimpanzees and marmosets. Journal of lnfectious Diseases 144, FUCHS, K., MOTZ, M., SCHREER, E., ZACHOVAL, R., DENHARDT, F. & ROGGENDORF, M. (1991). Characterization of nucleotide sequences from European hepatitis C virus isolates. Gene 103, GARSON, J. A., TEDDER, R. S., BRGGS, M., TUKE, P., GLAZEBROOK, J. A., TRUTE, A., PARKER, D., BARBARA, J. A. J., CONTERAS, M. & ALOYSUS, S. (1990a). Detection of hepatitis C viral sequences in blood donation by 'nested' polymerase chain reaction and prediction of infectivity. Lancet i, GARSON, J. A., TUKE, P. W., MAKRS, M., BRGGS, M., MACHN, S. J., PRESTON, F. E. & TEDDER, R. S. (1990b). Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-c-virus-contaminated factor V concentrates. Lancet ii, HARADA, S., WATANABE, Y., TAKEUCH, K., SUZUK, T., KATAYAMA, T., TAKEBE, Y., SATO,. & MYAMURA, T. (1991). Expression of processed core protein of hepatitis C virus in mammalian cells. Journal of Virology 65,
5 Short communication 1019 MAULER, R., MERKLE, W. & HLFENHAUS, J. (1987). nactivation of HTLV-LAV, hepatitis B and nonanonb hepatitis viruses by pasteurization in human plasma preparations. Developments in Biological Standardization 67, NASOFF, M. S., ZEHEDEE, S. L., NC-AOSPE, G. & PRNCE, A, M. (1991). dentification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proceedings of the National Academy of Sciences, U.S.A. 88, OGATA, N., ALTER, H. J., MLLER, R. H. & PURCELL, R. H. (1991). Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proceedings of the National Academy of Sciences, U.S.A. 88, OKAMOTO, H., OKADA, S., SUGYAMA, Y., YOTSUMOTO, S., TANAKA, T., YOSmZAWA, H., TSUDA, F., Mn'AKAWA, Y. & MAYUM, M. (1990). The 5'-terminal sequence of hepatitis C virus genome. Japanese Journal of Experimental Medicine 60, PRNCE, A., STEPHAN, W. & BROTMAN, B. (1983). Betapropiolactone ultraviolet irradiation: a review of its effectiveness against viruses in blood derivatives. Reviews of nfectious Diseases 5, SHMZU, Y. K., WENER, A. J., ROSENBLATr, J., WONG, D. C., SHAPRO, M., POPKN, T., HOUGHTON, M., ALTER, H. J. & PURCELL, R. H. (1990). Early events in hepatitis C virus infection of chimpanzees. Proceedings of the National Academy of Sciences, U.S.A. 87, VAN DER POEL, C. L., CUYPERS, H. T. M., REESlNK, H. W., WENER, A. J., QUAN, S., D NELLO, R., VAN BOVEN, J. J. P., WNKEL,., MULDER-FOLKERTS, D., EXEL-OEHLERS, P. J., SCHAASBERG, W., LEENTVAAR-KUYPERS, A., POLTO, A., HOUGHTON, M. & LELE, P. (1991). Confirmation of hepatitis C virus infection by new fourantigen recombinant immunoblot assay. Lancet i, WENER, A. J., KUO, G., BRADLEY, D. W., BONNO, F., SARACCO, G., LEE, C., ROSENBLATT, J., CHOO, Q. L. & HOUGHTON, M. (1990). Detection of hepatitis C viral sequences in nonanonb hepatitis. Lancet ii, 1-3. (Received 23 August 1991; Accepted.5 December 1991)
Polymerase Chain Reaction RNA Assays To Establish
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1992, p. 2145-2149 0095-1137/92/082145-05$02.00/0 Copyright 1992, American Society for Microbiology Vol. 30, No. 8 Use of Aminotransferase, Hepatitis C Antibody,
More informationserves a 750-bed university hospital, for measurement of Tokyo, Japan), the Abbott enzyme immunoassay (EIA; EIA
JOURNAL OF CLNCAL MCROBOLOGY, Nov. 1993, p. 2974-2980 0095-1137/93/112974-07$02.00/0 Copyright 1993, American Society for Microbiology Vol. 31, No. 11 Analysis of Discordant Test Results among Five Second-Generation
More informationDETECTION OF HEPATITIS C VIRUS cdna SEQUENCE BY THE POLYMERASE CHAIN REACTION IN HEPATOCELLULAR CARCINOMA TISSUES
Jpn. J. Med. Sci. Biol., 43, 89-94, 1990. Short Communication DETECTION OF HEPATITIS C VIRUS cdna SEQUENCE BY THE POLYMERASE CHAIN REACTION IN HEPATOCELLULAR CARCINOMA TISSUES Tetsuo YONEYAMA, Kenji TAKEUCHI,
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More informationRama Nada. - Malik
- 2 - Rama Nada - - Malik 1 P a g e We talked about HAV in the previous lecture, now we ll continue the remaining types.. Hepatitis E It s similar to virus that infect swine, so its most likely infect
More informationThe Alphabet Soup of Viral Hepatitis Testing
The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,
More informationNeutralizing Antibodies against Hepatitis C Virus and the
JOURNAL OF VIROLOGY, Mar. 1994, p. 1494-1500 Vol. 68, No. 3 00-538X/94/$04.00+0 Copyright D 1994, American Society for Microbiology Neutralizing Antibodies against Hepatitis C Virus and the Emergence of
More informationSerological Markers of Posttransfusion Hepatitis C Viral Infection
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1992, p. 552-556 Vol. 3, No. 3 95-1137/92/3552-5$2./ Copyright X) 1992, American Society for Microbiology Serological Markers of Posttransfusion Hepatitis C Viral
More informationEquilibrium Centrifugation Studies of Hepatitis C Virus: Evidence for Circulating Immune Complexes
JOURNAL OF VIROLOGY, Apr. 1993, p. 1953-1958 0022-538X/93/041953-06$02.00/0 Copyright ) 1993, American Society for Microbiology Vol. 67, No. 4 Equilibrium Centrifugation Studies of Hepatitis C Virus: Evidence
More informationInactivation of Hepatitis B Virus and Non-A, Non-B Hepatitis
INFECTION AND IMMUNITY, Aug. 1983, p.816-821 Vol. 41, No. 2 001 9-9567/83/080816-06$02.00/ Inactivation of Hepatitis B Virus and Non-A, Non-B Hepatitis by Chloroform STEPHEN M. FEINSTONE,* KATHLEEN B.
More information(Immunoblot) Analysis Using a Recombinant Vaccinia Virus Expression System
JOURNAL OF CLINICAL MICROBIOLOGY, May 1993, p. 1173-1178 0095-1137/93/051173-06$02.00/0 Copyright C) 1993, American Society for Microbiology Vol. 31, No. 5 Correlation of Serum Antibody Titers against
More informationChronic hepatitis C: new diagnostic tools and therapeutic strategies Damen, M.
UvA-DARE (Digital Academic Repository) Chronic hepatitis C: new diagnostic tools and therapeutic strategies Damen, M. Link to publication Citation for published version (APA): Damen, M. (1999). Chronic
More informationJune EQA schemes closed. Information on sample properties. Prof. Dr. Heinz Zeichhardt. Dr. Martin Kammel
June 2018 EQA schemes closed Information on sample properties Prof. Dr. Heinz Zeichhardt Dr. Martin Kammel Issued by: INSTAND Gesellschaft zur Förderung der Qualitätssicherung in medizinischen Laborarien
More informationالحترمونا من خري الدعاء
الحترمونا من خري الدعاء Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could be true or
More informationEditorial. Hepatitis C: From Laboratory to Bedside
Editorial Hepatitis C: From Laboratory to Bedside It has been 15 years since Feinstone and coworkers' at the National Institutes of Health described a type of hepatitis occurring in recipients of blood
More informationTRANSFUSION-ASSOCIATED HEPATITIS G VIRUS INFECTION AND ITS RELATION TO LIVER DISEASE
TRANSFUSION-ASSOCIATED HEPATITIS G VIRUS INFECTION AND ITS RELATION TO LIVER DISEASE THE INCIDENCE OF TRANSFUSION-ASSOCIATED HEPATITIS G VIRUS INFECTION AND ITS RELATION TO LIVER DISEASE HARVEY J. ALTER,
More informationDiagnostic Methods of HBV and HDV infections
Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection
More informationDetection of IgA-class anti-hev antibody
Detection of IgA-class anti-hev antibody Hiroaki OKAMOTO E IgA-HE IgA HEV E HEV E E E 10 E 1997 E E 1, 2 2001 E 3 HEV 4 1979 HEV 5 A B C A B C E 6, 7 E HEV E 8 11 2003 8 19 http:www.mhlw. go.jphoudou200308h0819-2.html
More informationSTEVE NISHIMURA FALL 1990 HEPATITIS C. Introduction
STEVE NISHIMURA FALL 1990 HEPATITIS C Introduction With the recent identification and sequencing of the viral genome of the hepatitis C virus (HCV) and the subsequent development of an ELISA assay, a wealth
More informationViral hepatitis. The word hepatitis means inflammation of the liver. There are five main types of viral hepatitis: A, B, C, D, E
Viral hepatitis The word hepatitis means inflammation of the liver There are five main types of viral hepatitis: A, B, C, D, E Hepatitis A and E are typically caused by ingestion of contaminated food or
More informationChanges in hepatitis B virus DNA polymerase in
Gut, 1979, 20, 190-195 Changes in hepatitis B virus DNA polymerase in relation to the outcome of acute hepatitis type B A. ALBERTI, S. DIANA, A. L. W. F. EDDLESTON, AND ROGER WILLIAMS From the Liver Unit,
More informationantibody screening in patients attending a clinic for sexually
J. Hyg., Camb. (1984), 93, 225-232 225 Printed in Great Britain Hepatitis B core antigen synthesised in Escherichia coli: its use for antibody screening in patients attending a clinic for sexually transmitted
More informationAcute Non-A, Non-B Hepatitis
GASTROENTEROLOGY 76:680-684, 1979 Acute Non-A, Non-B Hepatitis Prolonged Presence of the nfectious Agent in Blood EDWARD TABOR, M.D., MLTON APRL, D.V.M., LEONARD B. SEEFF, M.D., and ROBERT J. GERETY, M.D.,
More informationHEPATITIS VIRUSES. Other causes (not exclusively hepatitis v.)also called sporadic hepatitis: HEPATITIS A(infectious hepatitis)
Dept.of Microbiology/Virology Assist.prof. Shatha F. Abdullah HEPATITIS VIRUSES Medically important hepatitis v. (liver)are: 1.HAV 2.HBV 3.HCV 4.HDV 5.HEV 6.HGV Other causes (not exclusively hepatitis
More informationThe cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations Jackson B R, Busch M P, Stramer S L, AuBuchon J P
The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations Jackson B R, Busch M P, Stramer S L, AuBuchon J P Record Status This is a critical abstract of an economic evaluation that meets
More informationFalse Positive Tests for Anti-Hepatitis C Antibodies and the Problem of Notifying Blood Donors
International Journal of Epidemiology O International Epidemlological Association 1996 Vol. 25, o. Printed in Great Britain False Positive Tests for Anti-Hepatitis C Antibodies and the Problem of otifying
More informationThe ABCs of Viral Hepatitis Diagnosis. Ila Singh, M.D., Ph.D. P & S Viral Hepatitis. Hepatitis A, B, C, D, E and G viruses
The ABCs of Viral Hepatitis Diagnosis Ila Singh, M.D., Ph.D. P & S 14-453 is132@columbia.edu Viral Hepatitis Hepatotropic viruses Hepatitis A, B, C, D, E and G viruses Generalized infection plus infection
More informationFrequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India.
Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India. Cinzia Keechilot, Veena Shenoy 1,V Anil kumar 2,Lalita Biswas 3. MBBS student * Transfusion
More informationE E Hepatitis E SARS 29, Lancet. E A B Enterically-Transmitted Non-A, Hepatitis E. Virus HEV nm. 1.35g/cm s ALT AST HEV HEV
7850 2004 Hepatitis E Tian-Cheng LI Naokazu TAKEDA Tatsuo MIYAMURA SARS 8 Lancet E E E Hepatitis E VirusHEV E E HEV HEV E 1955 29,000 E E A A B Enterically-Transmitted Non-A, Non-B Hepatitis 1983 Balayan
More informationViral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a
Viral hepatitis Supervised by: Dr.Gaith presented by: Shaima a & Anas & Ala a Etiology Common: Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Less common: Cytomegalovirus EBV Rare: Herpes
More informationRibavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon
408 Journal of Hepatology, 1993; 19:408-412 1993 Elsevier Scientific Publishers Ireland Ltd, All rights reserved. 0168-8278/93/$06.00 HEPAT 01452 Ribavirin in the treatment of chronic hepatitis C unresponsive
More informationOriginally published as:
Originally published as: Ratsch, B.A., Bock, C.-T. Viral evolution in chronic hepatitis B: A branched way to HBeAg seroconversion and disease progression? (2013) Gut, 62 (9), pp. 1242-1243. DOI: 10.1136/gutjnl-2012-303681
More informationViral Hepatitis in India: A Report from Delhi
Viral Hepatitis in India: A Report from Delhi Mohammad Irshad (Corresponding author) Clinical Biochemistry Division, Department of Laboratory Medicine All India Institute of Medical Sciences, New Delhi-110029,
More informationHepatitis C: Progress and Problems
CLINICAL MICROBIOLOGY REVIEWS, Oct. 1994, p. 505-532 0893-8512/94/$04.00+0 Copyright 1994, American Society for Microbiology Vol. 7, No. 4 Hepatitis C: Progress and Problems JENNIFER A. CUTHBERT* Liver
More informationHBV : Structure. HBx protein Transcription activator
Hepatitis B Virus 1 Hepatitis B Virus 2 Properties of HBV a member of the hepadnavirus group Enveloped, partially double-stranded DNA viruses, smallest DNA virus Replication involves a reverse transcriptase
More informationWHO GUIDELINES ON ESTIMATION OF RESIDUAL RISK OF HIV, HBV OR HCV INFECTIONS VIA CELLULAR BLOOD COMPONENTS AND PLASMA
ENGLISH ONLY EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Geneva, 17 to 21 October 2016 WHO GUIDELINES ON ESTIMATION OF RESIDUAL RISK OF HIV, HBV OR HCV INFECTIONS VIA CELLULAR BLOOD COMPONENTS AND PLASMA
More informationHepa%%s E Virus Is it a Concern?
IPFA/PEI 17 th Workshop on Surveillance and Screening of Blood Borne Pathogens 26-27 May 2010, The Regent Esplanade Zagreb Hotel, Zagreb, Croa%a Hepa%%s E Virus Is it a Concern? Keiji Matsubayashi Hokkaido
More informationTesting for Viral Hepatitis A Practice Parameter
AJCP / TESTING FOR VIRAL HEPATITIS Testing for Viral Hepatitis A Practice Parameter Ronald A. Sacher, MD, FRCPC, 1 Stephen M. Peters, PhD, FAAM, 2 and John A. Bryan, MD 3 Key Words: Viral hepatitis; Laboratory
More informationViral hepatitis Blood Born hepatitis. Dr. MONA BADR Assistant Professor College of Medicine & KKUH
Viral hepatitis Blood Born hepatitis Dr. MONA BADR Assistant Professor College of Medicine & KKUH Outline Introduction to hepatitis Characteristics of viral hepatitis Mode of transmission Markers of hepatitis
More informationSerological Markers in Chimpanzees
INFECTION AND IMMUNITY, May 1979, p. 352-356 Vol. 24, No. 2 0019-9567/79/05-0352/05$02.00/0 Hepatitis B e-antigen and Its Correlation with Other Serological Markers in Chimpanzees CHUNG-MEI LING,* ISA
More informationVirion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics
Hepadnaviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Hepatitis viruses A group of unrelated pathogens termed hepatitis viruses cause the vast majority
More informationLearning Objectives: Hepatitis Update. Primary Causes of Chronic Liver Disease in the U.S. Hepatitis Definition. Hepatitis Viruses.
Learning Objectives: Hepatitis Update ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Upon attendance of this seminar and review of material provided, the attendees will be able to: 1. List hepatitis viruses
More informationDiagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)
Diagnostic Methods of HBV infection Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Hepatitis B-laboratory diagnosis Detection of HBV infection involves
More informationGuidance for Industry
Guidance for Industry Lookback for Hepatitis C Virus (HCV): Product Quarantine, Consignee Notification, Further Testing, Product Disposition, and Notification of Transfusion Recipients Based on Donor Test
More informationScreening donors and donations for transfusion transmissible infectious agents. Alan Kitchen
Screening donors and donations for transfusion transmissible infectious agents Alan Kitchen Aim Not to teach you microbiology To provide and awareness of the big picture To provide an understanding of
More informationAnti-HCV Reagent Pack (STM) PIGEM1244/102.0
Anti-HCV Reagent Pack (STM) PIGEM1244/102.0 Symbols used» 3 SN 4 Ó e i = 'n' tests 1 j Use by/expiration date (Year Month Day) Lot Number Serial number Catalogue number Attention, see instructions for
More informationHumoral Immune Response in Acute Hepatitis C Virus Infection
MAJOR ARTICLE Humoral Immune Response in Acute Hepatitis C Virus Infection Dale M. Netski, 1 Tim Mosbruger, 1 Erik Depla, 6 Geert Maertens, 6 Stuart C. Ray, 1,4 Robert G. Hamilton, 1,3 Stacy Roundtree,
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091606 Age 24 Years Gender Male 30/8/2017 92800AM 30/8/2017 94631AM 31/8/2017 90306AM Ref By Final HEATITIS A & B VIRUS EVALUATION HEATITIS A ANTIBODY (ANTI HAV),
More informationHepatitis C in Australia:
Hepatitis C in Australia: Epidemiology and Clinical Presentation (and a bit of virology ) A/Prof Mark Douglas Hepatitis C - Distribution Te and Jensen 2010 Clin Liver Dis Hepatitis C Epidemiology Estimated
More informationPast and Present Hepatitis G Virus Infections in Areas Where Hepatitis C is Highly Endemic and Those Where It Is Not Endemic
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1998, p. 110 114 Vol. 36, No. 1 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology Past and Present Hepatitis G Virus Infections in Areas Where
More informationReceived 21 August 2000/Returned for modification 14 December 2000/Accepted 19 March 2001
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2001, p. 3110 3114 Vol. 39, No. 9 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.9.3110 3114.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationEC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK
National Institute for Biological Standards and Control (NIBSC) EC Certificate - Full Quality Assurance System Approval Certificate Annex IV (excluding sections 4 and 6) of Council Directive 98/79/EC on
More informationJ. L. Melnick. Introduction. Hepatitis B Antigens. VIROLOGY l Melnick l HEPATITIS VIRUSES 341
VIROLOGY l Melnick l HEPATITIS VIRUSES 341 HEPATITIS VIRUSES J. L. Melnick Discovery of a surface antigen closely associated with the agent of viral he$atitis B has hel$ed pave the way for work on a vaccine
More informationDocumentation, Codebook, and Frequencies
2 Documentation, Codebook, and Frequencies Laboratory Component: Hepatitis B: core antibody, surface antibody and surface antigen; Hepatitis C: confirmed antibody; Hepatitis D antibody Survey Years: 2003
More informationHepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-hcv antibodies (third-generation assays)
Nephrol Dial Transplant (995) : -9 Original Article IMephrology Dialysis Transplantation Hepatitis C virus (HCV) infection in haemodialysed patients: and anti-hcv antibodies (third-generation assays) A.-M.
More informationLaboratory Diagnosis of Viral Infections. G. Jamjoom 2005
Laboratory Diagnosis of Viral Infections G. Jamjoom 2005 Five Main Techniques: Virus Culture and Isolation Serology Rapid Detection of Viral Antigens Detection of Viral Nucleic Acid Electron Microscopy
More informationImpact of Testing Strategies to Reduce Transmission Risk for HBV. Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013
Impact of Testing Strategies to Reduce Transmission Risk for HBV Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013 Overview of SANBS SANBS is a private not for profit company
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Schedule of Accreditation 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK National Infection Service, Public Health England Colindale 61 Colindale Avenue London NW9 5EQ Contact: Dr Sanjiv
More informationEvaluation of a Novel Serotyping System for Hepatitis C Virus: Strong Correlation with Standard Genotyping Methodologies
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1995, p. 2978 2983 Vol. 33, No. 11 0095-1137/95/$04.00 0 Copyright 1995, American Society for Microbiology Evaluation of a Novel Serotyping System for Hepatitis C
More informationViral Hepatitis. Author: Nicolene Naidu
Viral Hepatitis Author: Nicolene Naidu Bachelor of Biological Science (Cellular Biology), Bachelor of Medical Science (Medical Microbiology) (Honours) The liver is the largest gland in the human body and
More informationStudy on Efficacy of Hepatitis B Immunization in Vaccinated Beta thalassemia Children in Tehran
Original Article Iran J Pediatr Jun 2010; Vol 20 (No 2), Pp:211-215 Study on Efficacy of Hepatitis B Immunization in Vaccinated Beta thalassemia Children in Tehran Zohreh Sharifi*, phd; Saeideh Milani,
More informationthat - 150,000 new cases of non-a, non-b viral hepatitis/ HCV infection occur yearly, and that 2 50% become chronic
Direct Detection of Circulating Hepatitis C Virus RNA Using Probes from the 5' Untranslated Region Ke-Qin Hu, Chang-Hong Yu, and John M. Vierling Departments ofmedicine, Cedars-Sinai Medical Center and
More informationHAV HBV HCV HDV HEV HGV
Viral Hepatitis HAV HBV HCV HDV HEV HGV Additional well-characterized viruses that can cause sporadic hepatitis, such as yellow fever virus, cytomegalovirus, Epstein-Barr virus, herpes simplex virus, rubella
More informationExcretion of bluetongue virus in cattle semen: a feature of laboratory-adapted virus
Vet. Ital., 40 (4), 497-501 Bluetongue virus and disease Excretion of bluetongue virus in cattle semen: a feature of laboratory-adapted virus P.D. Kirkland (1), L.F. Melville (2), N.T. Hunt (2), C.F. Williams
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091608 Age 26 Years Gender Female 30/8/2017 92900AM 30/8/2017 94717AM 31/8/2017 90216AM Ref By Final HEATITIS ACUTE VIRUS CONFIRMATION HEATITIS A ANTIBODY (ANTI HAV),
More informationHEPATITIS C VIRUS (HCV) IS A BLOOD-BORNE. Laboratory diagnosis of viral hepatitis C The Sultan Qaboos University Hospital experience
SQU JOURNAL FOR SCIENTIFIC RESEARCH: MEDICAL SCIENCES 2003 VOL 5, NO. 1 2, 15 20 SULTAN QABOOS UNIVERSITY Laboratory diagnosis of viral hepatitis C The Sultan Qaboos University Hospital experience *Said
More informationHepatitis C virus (HCV) is a global public health problem,
Molecular Clones of Hepatitis C Virus: Applications to Animal Models Michael Gale, Jr., and Michael R. Beard Abstract Hepatitis C virus (HCV) is a global public health problem, with approximately 3% of
More informationHepatitis A-E Viruses. Dr Nemes Zsuzsanna
Hepatitis A-E Viruses Dr Nemes Zsuzsanna Viral Hepatitis - Historical Perspectives Infectious A E Enterically transmitted Viral hepatitis NANB Serum B D C Parenterally transmitted HGV, TTV, SEN, other
More informationPurification of viral nucleic acid from serum, plasma, cell-free biological fluids MACHEREY- NAGEL
Purification of viral nucleic acid from serum, plasma, cell-free biological fluids Purification of viral nucleic acid from serum, plasma, cell-free biological fluids viral RNA: viral DNA: NucleoSpin RNA
More informationDetermination of the temporal pattern and importance of BALF1 expression in Epstein-Barr viral infection
Determination of the temporal pattern and importance of BALF1 expression in Epstein-Barr viral infection Melissa Mihelidakis May 6, 2004 7.340 Research Proposal Introduction Apoptosis, or programmed cell
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091650 Age 49 Years Gender Male 29/8/2017 120000AM 29/8/2017 100248AM 29/8/2017 105306AM Ref By Final HEATITIS, VIRAL, COMREHENSIVE ANEL HEATITIS A ANTIBODY (ANTI
More informationHEALTH SERVICES POLICY & PROCEDURE MANUAL
PAGE 1 of 5 PURPOSE To provide guidelines on the treatment and care of patients with Hepatitis. POLICY Hepatitis is an injury to hepatic cells and an inflammatory process in the liver. The major causes
More informationMicropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ
www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons
More informationNon-reproductive tissues and cells
Colour key Tested pathogen VIRAL Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legy binding on national level More stringent testing - recommended on national level Not
More informationHerpes virus co-factors in HIV infection
Herpes virus co-factors in HIV infection Dr Jane Deayton Barts and the London Queen Mary School of Medicine Introduction Herpes viruses very common and often coexist with HIV Establish life-long latent
More informationSize nm m m
1 Viral size and organization Size 20-250nm 0.000000002m-0.000000025m Virion structure Capsid Core Acellular obligate intracellular parasites Lack organelles, metabolic activities, and reproduction Replicated
More informationHepatitis B (Part 1 - intro)
Hepatitis B (Part 1 - intro) The Hepatitis B virus (HBV) l Virology Discovered in 1966 double-stranded DNA virus l family of hepadnaviruses l HBV unique to Humans (Primates too in laboratory studies) no
More informationHIV Basics: Clinical Tests and Guidelines
HIV Basics: Clinical Tests and Guidelines ACTHIV 2010 Zelalem Temesgen MD Mayo Clinic Topics Baseline laboratory evaluation Laboratory monitoring through the continuum of care Patients not on antiretroviral
More informationHBV Core and Core-Related Antigen Quantitation in Chinese Patients with. Chronic Hepatitis B Genotype B and C Virus Infection
Title page HBV Core and Core-Related Antigen Quantitation in Chinese Patients with Chronic Hepatitis B Genotype B and C Virus Infection Short Title: Quantitation of HBc and HBcrAg in Chinese patients Akinori
More informationHepatitis C Best Practice Guidelines For Local Health Departments
Hepatitis C Best Practice Guidelines For Local Health Departments LHDs are responsible for investigating and reporting all physician reported cases of acute hepatitis C (HCV). For clients known to have
More informationHepatitis C. Core slides
Hepatitis C Core slides This material was prepared by the Viral Hepatitis Prevention Board The slides (or subsets) can be reproduced for educational use only, with reference to the original source and
More informationScreening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: A U.S. National Collaborative Study
Kidney Intemational Vol. 46 (1994), pp. 886 892 Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: A U.S. National Collaborative Study BRIAN J.G. PEREIRA, TERESA
More informationOfficial Journal of the European Communities COMMISSION
16.5.2002 EN Official Journal of the European Communities L 131/17 COMMISSION COMMISSION DECISION of 7 May 2002 on common technical specifications for in vitro-diagnostic medical devices (notified under
More informationRecommended laboratory tests to identify influenza A/H5 virus in specimens from patients with an influenza-like illness
World Health Organization Recommended laboratory tests to identify influenza A/H5 virus in specimens from patients with an influenza-like illness General information Highly pathogenic avian influenza (HPAI)
More informationProtection against persistence of hepatitis C
Mechanisms of disease Protection against persistence of hepatitis C Shruti H Mehta, Andrea Cox, Donald R Hoover, Xiao-Hong Wang, Qing Mao, Stuart Ray, Steffanie A Strathdee, David Vlahov, David L Thomas
More informationVIRUSES. 1. Describe the structure of a virus by completing the following chart.
AP BIOLOGY MOLECULAR GENETICS ACTIVITY #3 NAME DATE HOUR VIRUSES 1. Describe the structure of a virus by completing the following chart. Viral Part Description of Part 2. Some viruses have an envelope
More informationBruce A. Luxon, MD, PhD, FACG Consultant: Vertex Speakers Bureau: Merck
Bruce A. Luxon, MD, PhD, FACG Consultant: Vertex Speakers Bureau: Merck Bruce A. Luxon, MD, Ph.D. Anton and Margaret Fuisz Chair in Medicine Professor and Chair Department of Medicine Georgetown University
More informationGene Vaccine Dr. Sina Soleimani
Gene Vaccine Dr. Sina Soleimani Human Viral Vaccines Quality Control Laboratory (HVVQC) Titles 1. A short Introduction of Vaccine History 2. First Lineage of Vaccines 3. Second Lineage of Vaccines 3. New
More informationHepatitis B Antiviral Drug Development Multi-Marker Screening Assay
Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay Background ImQuest BioSciences has developed and qualified a single-plate method to expedite the screening of antiviral agents against
More informationFulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus
Gut 1999;45:613 617 613 Liver Research Unit, Chang Gung Memorial Hospital and Medical College, Taipei, Taiwan C M Chu CTYeh Y F Liaw Correspondence to: Dr C M Chu, Liver Research Unit, Chang Gung Memorial
More informationHepatitis C Virus (HCV)
Clinical Practice Guidelines Hepatitis C Virus (HCV) OBJECTIVE The purpose is to guide the appropriate diagnosis and management of Hepatitis C Virus (HCV). GUIDELINE These are only guidelines, and are
More informationUses and Misuses of Viral Hepatitis Testing. Origins of Liver Science
Uses and Misuses of Viral Hepatitis Testing Richard S Lang, MD, MPH, FACP Chairman, Preventive Medicine Vice-Chair, Wellness Institute Raul J Seballos, MD, FACP Vice-Chair, Preventive Medicine Wellness
More informationIgM antibody response to hepatitis C virus in end-stage renal disease
Nephrol Dial Transplant (1996) 11: 314-318 Original Article Nephrology Dialysis Transplantation IgM antibody response to hepatitis C virus in end-stage renal disease F. Fabrizi, G. Lunghi, I. Guarnori,
More informationRadioimmunoassay for Detection of Hepatitis B e Antigen and its Antibody. Results of Clinical Evaluation
Radioimmunoassay for Detection of Hepatitis B e Antigen and its Antibody. Results of Clinical Evaluation ISA K. MUSHAHWAR, PH.D., LARRY C. MCGRATH, PH.D., JAMES DRNEC, PH.D., AND LACY R. OVERBY, PH.D.
More informationHBV PUBLIC HEALTH IMPLICATIONS
جزايری دکتر سيد محمد آزمايشگاه ھپاتيت B -دانشکده بھداشت ويروس شناسی- گروه دانشگاه علوم پزشکی تھران کنگره ارتقا کيفيت- ١٣٩٢ HBV PUBLIC HEALTH IMPLICATIONS 2 billion people have been infected by HBV worldwide.
More informationfor detecting antibody to hepatitis B virus core antigen
Journal of Clinical Pathology, 1978, 31, 832-836 Routine use of counter-immunoelectrophoresis test for detecting antibody to hepatitis B virus core antigen R. FREEMAN AND M. H. HAMBLING From the Virology
More informationSome HCV History 1970s: many cases reported called non-a, non-b hepatitis
Hepatitis C virus 1 Some HCV History 1970s: many cases reported called non-a, non-b hepatitis 1988: hepatitis C virus identified 1990: antibody screening tests available 1992: better tests to insure safety
More informationShort title: BENEFIT STUDY, STUDY REPORT (ML25614) Synopsis/Abstract
A Multicenter, prospective, Non-Interventional Study Evaluating Response Parameters during and after Therapy with PEGASYS (Peginterferon alfa-2a 40KD) in Subjects with HBeAg positive or HBeAg negative
More information